Anhedonia, defined as dysfunction in the experience of pleasant emotions, is a hallmark symptom of the schizophrenia spectrum. Of interest, it is well documented that patients with schizophrenia, at least as a group, do not show reductions in their state experience of pleasant stimuli. However, there is emerging evidence to suggest that individuals with schizotypy-defined as the personality organization reflecting the latent vulnerability for schizophrenia-do show these state deficits. This is paradoxical in that schizophrenia reflects a more pathological state in virtually every conceivable domain as compared with schizotypy. The present study examined self-reported affective reactions to neutral-, bad-, and goodvalenced stimuli in individuals with psychometrically defined schizotypy and schizophrenia. Two separate control groups were also included, comprising psychometrically defined controls and stable outpatients with affective disorders. With no exceptions, the schizotypy group reported significantly less pleasant affect for each of the three conditions than each of the other groups. Conversely, the schizophrenia group did not statistically differ from the control groups for any of the conditions. Within both the schizotypy and schizophrenia groups, severity of negative symptoms/traits was associated with less pleasant report. We found that individuals with prominent negative symptoms and traits from the schizophrenia and schizotypy groups resembled each other in terms of state anhedonia. The present findings did not appear to reflect comorbid depression or anxiety. Our discussion centers on this apparent paradox in the schizophrenia spectrum-that individuals with schizotypy exhibit state anhedonia, whereas patients with schizophrenia do not.
state anhedonia, whereas patients with schizophrenia do not. This is paradoxical in the sense that schizophrenia is by definition much more severe in virtually every illness-related aspect as compared with schizotypy.
There are many limitations regarding the extant literature on state anhedonia in schizotypy that make conclusions tenuous at this time. First, no study to our knowledge has directly compared subjective reactions between individuals with schizophrenia and schizotypy. Given that studies differ wildly in the format, duration, and intensity of stimuli used, it is impossible to conclude that individuals with schizotypy are more anhedonic than patients with schizophrenia without direct comparison using the same moodinduction methods. Second, affect is a more complicated construct than conceptualized in many prior studies. Most prior studies have assessed pleasant and unpleasant affective states as occurring on opposing ends of a single continuum. Given that pleasant and unpleasant systems appear to be distinct (Larsen, McGraw, & Cacioppo, 2001) , it is important to consider pleasant and unpleasant responses separately when attempting to understand anhedonia. Third, little attention has been given to distinguishing schizotypy from depression or anxiety in evaluating state emotions. This is important because some aspects of schizotypy, notably those involving negative schizotypy traits, can resemble depression and anxiety symptoms. Fourth, it is presently unclear whether individuals with schizotypy show "state anhedonia" only to goodvalenced stimuli or to stimuli more generally. Of the studies that found significant group differences in state anhedonia, nine of 10 reported these differences in response to good-valenced stimuli (i.e., all but Gooding, Davidson, Putnam, & Tallent, 2002) , three reported differences in response to neutral-valenced stimuli (Fitzgibbons & Simons, 1992; Leung et al., 2010; , and only two reported differences in response to bad-valenced stimuli (Gooding, Davidson, Putnam, & Tallent, 2002; Mathews & Barch, 2006) .
A final limitation regards symptom heterogeneity, as both schizophrenia and schizotypy are composed of a range of positive, negative, and disorganization symptom/trait dimensions (Bentall, Claridge, & Slade, 1989) . All but three of the 12 prior laboratory studies of anhedonia in schizotypy have defined schizotypy solely with regard to negative traits, and all but two have defined negative traits with respect to a single characteristic: anhedonia. Thus, the issue of whether state anhedonia is generalizable to the schizotypy population, which evinces a broad swath of negative (i.e., constricted affect) and non-negative (i.e., positive and disorganized) schizotypal traits has yet to be resolved. Moreover, it is presently unclear whether state anhedonia, if present, is differentially related to specific symptom/trait dimensions. It stands to reason that individuals with negative symptoms and traits would show the most pronounced state anhedonia, as negative symptoms/traits are defined, in part, by trait or observer-rated anhedonia. However, available studies are mixed in this regard. With respect to schizotypy, two studies have reported that state anhedonia is more pronounced in individuals with negative versus other schizotypal traits Kerns et al., 2008) , whereas one has not . Similar inconsistency is seen in schizophrenia, with at least two studies finding and two studies failing to find evidence of a relationship between negative symptoms and state anhedonia (Cohen, Docherty, Nienow, & Dinzeo, 2003; Strauss, Allen, Ross, Duke, & Schwartz, 2010 , but see Earnst & Kring, 1999; Trémeau et al., 2009) . Moving forward, understanding how state anhedonia manifests across the heterogeneous manifestations of the schizophrenia spectrum is critical.
The present study examined subjective responses to laboratory stimuli in a large heterogeneous group with psychometrically defined schizotypy and a separate group of stable outpatients with schizophrenia. Also included were two separate control groups: a sample of nonschizotypal young adults recruited from the same setting as the schizotypy group and a sample of stable outpatients with affective disorders recruited from the same setting as the schizophrenia group. We addressed limitations of prior studies by (a) directly comparing subjective reactions to evocative stimuli from separate schizotypy, schizophrenia, and control groups; (b) employing separate pleasant and unpleasant ratings of stimuli; (c) separately measuring depression and anxiety to allow for statistical control of these variables; (d) including a range of good-, bad-, and neutral-valenced stimuli; and (e) employing a schizotypy group with a diverse set of positive, negative, and disorganized traits. Our chief aims were to address the following questions: 1) do individuals with psychometrically defined schizotypy demonstrate state anhedonia as compared with patients with schizophrenia and patient and nonpatient controls?; 2) to what degree do these group differences, if present, reflect comorbid depression and anxiety?; 3) do individuals with schizotypy demonstrate more self-reported trait anhedonia as compared with the other groups?; and 4) is state anhedonia significantly related to negative but not other symptoms/traits in the schizotypy and schizophrenia groups?
Method
Subjects. Subjects were either recruited from a large public university or a community mental health outpatient clinic.
Patient groups. The patient groups included 32 adults diagnosed with schizophrenia according to the Diagnostic & Statistical Manual of Mental Disorders-4th edition (DSM-IV; American Psychiatric Association, [APA], 1994) and 25 patients with a history of DSM-IV unipolar (n ϭ 13) or bipolar (n ϭ 12) affective disorders. The unipolar/bipolar group was included to provide evaluation of a group of outpatients with severe mental illness other than schizophrenia for comparison to the schizophrenia group. Individuals in the patient control group had no history of schizophrenia spectrum disorder. Concerns could be raised that this group was overly heterogeneous in that it comprised individuals with unipolar and bipolar affective disorders who potentially differed in state anhedonia. This did not appear to be the case in our data, as there were no statistically significant differences in level of state pleasant affect for the neutral, good, or bad conditions between these groups of individuals (ps Ͼ .05).
Diagnoses were made based on information obtained from the patients' medical records and from a structured clinical interview (SCID; First, Gibbon, Spitzer, & Williams, 1996) . Exclusion criteria included: a) Global Assessment of Functioning rating (GAF; APA, 1994) below 30, indicating a level of psychosis that could interfere with participation in the study; b) documented evidence of mental retardation from the medical records; c) current or historical DSM-IV diagnosis of alcohol or drug abuse suggestive of severe physiological symptoms (e.g., delirium tremens, repeated loss of consciousness); and d) history of significant head trauma (requiring overnight hospitalization). All patients were clinically stable at the time of testing and were receiving pharmacotherapy under the supervision of a multidisciplinary team. All patients were prescribed psychotropic medications at the time of testing, and there was considerable variability in type, dosage, and medium (i.e., depot vs. oral) across patients.
Schizotypy and nonpatient control groups. Subjects from the schizotypal and nonpatient control groups were undergraduate freshmen and sophomores (N ϭ 8,993) who were approached by e-mail to participate in an online survey and offered a chance to win monetary prizes. Embedded within this survey were a consent form, basic demographic questions, a modified version of the Schizotypal Personality Questionnaire-Brief, (SPQ-B), which featured an expanded response format (Cohen, Matthews, Najolia, & Brown, 2010) , the Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983) , and infrequency items (Chapman & Chapman, 1983) . The final screening sample included 1,371 complete, valid responses (defined as an infrequency score Ͼ2). Based on evidence that schizotypy is a categorical construct with a population incidence approaching 10% (see Lenzenweger, 2006 , for a conceptual review), we adopted a conservative strategy where the top 5% of scorers (1.65 standard deviations [SD] from the ethnicityand gender-determined means) on the positive/disorganization (n ϭ 49) and/or negative (n ϭ 32) subscales were invited to participate in the laboratory phase of the study. Positive (i.e., ideas or reference, suspiciousness, magical thinking, and unusual perceptions), disorganization (i.e., odd speech, eccentric behavior), and negative (i.e., constricted affect, no close friends) subscales were employed. To address concerns that depressive symptoms can give "false positives" on negative schizotypy scales, individuals scoring high on the negative scale were only considered eligible if they a) also showed elevation on the positive or disorganization scales, or b) had a depression scale score from the BSI (Derogatis & Melisaratos, 1983) below their gender-and ethnicitydetermined mean. Control subjects were identified and included based on scores below the ethnicity-and gender-determined means for each of the positive, negative, and disorganization SPQ factors. Three hundred and eighty seven individuals met these criteria, of which 35 were selected and agreed to participate.
Diagnostic and symptom ratings. The Brief Psychiatric Rating Scale (BPRS; Lukoff, Nuechterlein, & Ventura, 1986) and Scales for the Assessment of Positive and Negative symptoms (SAPS and SANS; Andreasen, 1984 Andreasen, , 1989 , respectively) were used to measure patients' symptoms. For the BPRS, a measure of broad psychiatric symptoms, factor subscale scores reflecting positive (i.e., bizarre behavior, suspiciousness, unusual thought content, disorientation, and hallucinations items), negative (i.e., selfneglect, blunted affect, motor retardation, and emotional withdrawal items), depressive (i.e., depression, guilt, suicidality, and anxiety items), and mania/excitement (i.e., motor hyperactivity, elevated mood, excitement, distractibility, hostility, and grandiosity items) symptoms (defined in Ventura, Nuechterlein, Subotnik, Gutkind, & Gilbert, 2000) were employed here. For the SAPS and SANS, measures of schizophrenia spectrum symptoms, summary scores reflecting positive (i.e., global delusion and hallucination scores), disorganization (i.e., global thought disorder and bizarre behavior scores), alogia-blunted affect (i.e., global alogia and blunted affect scores), and anhedonia-avolition (i.e., global anhedonia and avolition scores) were used. Alogia-blunted affect and anhedonia-avolition were examined separately here, as opposed to being combined into a single negative symptom score, based on evidence that these are distinct symptom dimensions (Blanchard & Cohen, 2006) . Preliminary diagnoses and symptom ratings were made by one of four doctoral level students who were trained to criterion (intraclass correlation coefficient values Ͼ .70). Diagnoses and ratings were based on information obtained from medical records, the patients' treatment teams, and self-report and behavioral observations made during the research interviews. All diagnoses and ratings were videotaped and reviewed during a monthly case conference meeting that was led by a licensed clinical psychologist with considerable diagnostic experience (Alex S. Cohen). Final ratings and diagnoses were recorded when full agreement by the case conference members was made.
Self-reported symptoms and trait affect. All subjects in this study were asked to complete the BSI (Derogatis & Melisaratos, 1983 )-a commonly used self-report measure of symptoms endorsed in the last month. The anxiety and depression scales, combined in order to reduce the overall number of analyses, were employed here. Trait affectivity was measured using the 20-item Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988) with the instructions to indicate how they "generally feel."
Mood-induction task. Subjects were asked to rate their mood following separate good-, bad-, and neutral-valenced emotioninduction conditions. During these conditions, subjects were presented with images from the International Affective Picture System (IAPS; Lang, Bradley, & Cuthbert, 2005) for 20 seconds each. For the good and bad conditions, images were selected with extreme valence ratings and either high (IAPS images 8185, 8030, 8490, 8370, 8502, and 5971, 1300, 6550, 3010, 6230, respectively) or low (IAPS images 5000, 2370 (IAPS images 5000, , 5010, 1610 (IAPS images 5000, , 5200, and 9220, 9265, 2722 arousal ratings. For the neutral condition, images were selected that were rated within the neutral range by the norming sample (i.e., valence score 4 -6; IAPS images 7175, 7010, 7004, 7490, 7187, 8160, 8179, 5950, 1931, 1321) .
1 Block order and picture presentation order within blocks were randomized. In an effort to reduce the overall cognitive and speaking burden on the patients, they viewed slightly fewer images in each condition: three versus five. Therefore, each block was 100 s long for the nonpatient groups and 60 s for the patient groups. To promote cognitive and emotional processing of the stimuli, subjects were asked to verbalize their reactions regarding "how the picture relates to you" and "how it makes you feel" (see Cohen, Minor, Najolia, & Hong, 2009; Cohen, Hong, & Guevara, 2010 for validation data concerning this narrative moodinduction procedure). Following each block, subjects evaluated their affective state "at that moment" using separate pleasant and unpleasant-based Self-Assessment Manikins (SAMS; Lang et al., 2005) ranging from 1 (neutral emotion) to 9 (extreme pleasant or unpleasant emotion, for each scale respectively). Blocks were separated by a 30-s interval during which subjects were instructed to "relax and breathe deeply." 1 High and low arousal stimuli were employed in this study to provide breadth of stimuli within each valence category. There were no statistically significant differences in state pleasant or unpleasant ratings between the high and low arousal conditions for either the good or bad conditions (p's Ͼ .05).
Analyses. The analyses were conducted in four steps. First, we computed and compared descriptive and clinical variables between the schizophrenia, schizotypy, and the patient and nonpatient control groups to determine whether any of these variables needed to be considered in subsequent analyses. Second, we employed a group (i.e., schizotypy, college control, schizophrenia, patient control) by condition (i.e., good, bad, neutral) by affect rating (i.e., pleasant, unpleasant) analysis of variance to determine whether pleasant and unpleasant affect ratings differed across the four groups and the extent to which affect ratings changed as a function of our emotion induction. We were primarily interested in the group by affect interaction based on our hypothesis that the schizotypy group would be significantly lower in pleasant but not unpleasant ratings for each condition as compared with the other groups. We were also interested in the condition by affect rating interaction, as a significant value would suggest that pleasant and unpleasant ratings changed differently as a function of moodinduction condition. Third, we compared trait affect between the four groups. Finally, we computed correlations between symptoms/traits measured from the SAPS/SANS and SPQ and pleasant and unpleasant ratings within the schizotypy and schizophrenia groups to help determine the degree to which abnormalities in state experience reflect specific symptom/trait dimensions. Post hoc follow-up analyses were conducted to clarify these findings (see below for elaboration).
Results
Demographic and descriptive variables. Group-wise comparisons (see Age was highest in the patient control group, next highest in the schizophrenia group, and lowest in the nonpatient groups (ps Ͻ .05). Education was significantly lower in the patient versus nonpatient groups (ps Ͻ .05), but no other significant differences in education were noted. Finally, the schizophrenia versus patient control group had significantly more severe BPRS negative and positive symptoms (ts[55] ϭ 2.03 and 3.67, ps Ͻ .04, p 2 ϭ .21), but the groups were not statistically dissimilar with respect to other BPRS symptom factors (ps Ͼ .10). The schizophrenia group was also significantly more severe in SAPS/SANS symptoms for each subscale (ps Ͻ .01), except for anhedonia-avolition (ps Ͼ .10).
We next examined whether differences in age or ethnicity were associated with any of our six emotion report-dependent measures. Age was associated with increased unpleasant ratings to neutral stimuli (r[171] ϭ .16, p Ͻ .05) but was unrelated to ratings for any of the other conditions (ps Ͼ .05). Non-Caucasian versus Caucasian subjects rated the neutral stimuli as significantly more pleasant, t(171) ϭ 2.22, p Ͻ .03, d ϭ 0.53, but they were similar in response to the other stimuli and in unpleasant report for all conditions (ps Ͼ .05). In order to ensure that our findings were not due to confounding effects of ethnicity, we recomputed all analyses of unpleasant and pleasant ratings of neutral stimuli separately for Caucasians and Non-Caucasians. We also recomputed all analyses controlling for age and depression-anxiety scores from the BSI. There were no substantive changes controlling for these variables.
Group differences in affect. The groups were then compared in affect ratings across the three conditions. The group, F(3,  169) 2 ϭ .02, interactions were not statistically significant. Post hoc analyses were then conducted. The group effect reflected the schizotypy group reporting overall lower ratings than the patient control group (mean difference ϭ .58, p ϭ .02, d ϭ .24). The affect main effect reflected the unpleasant ratings being significantly lower than the pleasant ratings for each condition (ts[172] Ͼ 2.51, ps Ͼ .01, ds Ͼ .32). The group by affect interaction reflected the schizotypy group being significantly lower than each of the other groups for each of pleasant ratings (ps Ͻ .001), but not being significantly different from any of the other groups in unpleasant affect for any of the conditions (ps Ͼ .17). There were no other significant group differences for any of the conditions. The condition by affect interaction reflected different patterns of affect ratings across the three conditions. For subjects as a group, pleasant ratings in the good condition were higher than for the neutral, t(172) ϭ 2.82, p ϭ .005, d ϭ .43, and bad, t(172) ϭ 11.53, p Ͻ .001, d ϭ 1.76, conditions, and pleasant ratings for the neutral condition were higher than for the bad, t(172) ϭ 12.30, p Ͻ .001, d ϭ 1.88 condition. A different pattern emerged for the unpleasant ratings: unpleasant ratings from the bad condition were higher than for the neutral, t(172) ϭ 8.80, p Ͻ .001, d ϭ 1.34 and good, t(172) ϭ 9.61, p Ͻ .001, d ϭ 1.47 conditions, and unpleasant ratings were higher for the neutral versus good, t(172) ϭ 2.55, p ϭ .01, d ϭ .39 conditions. In sum, 1) the emotion-induction procedure was largely effective based on the significant condition by affect effect; 2) the group by condition interaction was not statistically different suggesting emotion induction was not demonstratively different across groups; and 3) individuals with schizotypy reported significantly less pleasant emotion than each other group for each condition, but did not differ in unpleasant emotion for any of the conditions. These data are summarized in Figures 1 and 2 .
Group differences in trait affect. Means and standard deviations are presented in Table 1 . There were statistically significant group differences in both positive, F(3, 170) ϭ 7.70, p Ͻ .001, p 2 ϭ .12, and negative, F(3, 170) ϭ 10.17, p Ͻ .001, p 2 ϭ .16, trait affect. The patient and schizotypy groups were not statistically different in either of these variables (ps Ͼ .05). Nonpatient controls had significantly higher positive and lower negative trait affect than the other groups (ps Ͻ .05). Thus, in contrast to what was seen for measures of state pleasure, the schizotypy and patient groups were similar in trait affect report.
Variability in state affect as a function of positive, negative, and disorganization symptoms/traits. Correlations, computed between the state pleasant and unpleasant ratings and the schizophrenia/schizotypy symptom scores are presented in Table 2 . There are several patterns worth noting. First, for both the schizophrenia and schizotypy groups, decreasing pleasant ratings were, for the most part, significantly associated with more severe negative symptoms. For the schizophrenia group, this was limited to blunt affect-alogia as opposed to anhedonia-avolition symptoms. Second, none of the other symptoms/traits were significantly associated with pleasant ratings. Finally, none of the symptom dimensions were significantly associated with unpleasant ratings for any of the conditions. Although interesting, the above correlations did not speak to three key issues regarding state pleasant ratings across groups, including whether: 1) state pleasant ratings differed between the negative schizotypy and negative schizophrenia groups, 2) the non-negative schizotypy group showed state anhedonia, and 3) the negative schizophrenia group showed state anhedonia. To answer these questions, we conducted post hoc t tests after divid- ing the schizotypy and schizophrenia groups into separate negative and non-negative groups. These groups included schizotypal individuals with (i.e., SPQ negative subscale score z-score Ն1.65; mean [M] Ϯ standard deviation [SD] ϭ 1.96 Ϯ .25; n ϭ 30) versus without negative (i.e., SPQ negative subscale score z-score Ͻ1.00; M Ϯ SD ϭ .08 Ϯ .71; n ϭ 28) traits and schizophrenia patients with (i.e., alogia and/or blunted affect score Ն "mild"; M Ϯ SD ϭ 1.06 Ϯ 1.88; n ϭ 16) versus without (i.e., all other schizophrenia patients; M Ϯ SD ϭ .88 Ϯ .89; n ϭ 16) blunt affect-alogia. These cutoff scores reflect those used in prior studies from our lab (e.g., Cohen, Alpert, Nienow, Dinzeo, & Docherty, 2008; . For presentation purposes, the blunt affect-alogia schizophrenia group will be referred to as the "negative" schizophrenia group even though only some negative symptoms are captured. This issue will be expounded in the discussion section.
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Regarding the first question-whether the negative schizotypy and negative schizophrenia groups differed in pleasant report, results suggest that the two groups were relatively similar for each condition (ts Ͻ 1.03, ps Ͼ .31, ds Ͻ 0.28). Thus, negative patients and schizotypy subjects were similar in state anhedonia. Regarding the second question-whether state anhedonia occurred in the non-negative schizotypy group, we compared pleasant ratings between the negative and non-negative schizotypy and nonpatient control groups. Results suggest that the schizotypy groups were not statistically different for the good condition, t(56) ϭ 1.65, p ϭ .11, d ϭ 0.43, but that the negative schizotypy group was significantly more anhedonic for the neutral, t(56) ϭ 2.94, p ϭ .005, d ϭ 0.79, and bad, t(56) ϭ 3.01, p ϭ .004, d ϭ 0.80, conditions. On the other hand, the non-negative schizotypy group was significantly lower in pleasant report than nonpatient controls for the good, t(61) ϭ 2.49, p ϭ .02, d ϭ 0.60, but not for the neutral or bad (ts Ͻ 0.95, ps Ͼ .35, ds Ͻ 0.25) conditions. This suggests that state anhedonia in the non-negative schizotypy group was present only for the good condition. Regarding the third question-whether the negative schizophrenia group showed state anhedonia, we compared this group to the non-negative schizophrenia and the nonpatient and patient control groups. With only two exceptions (one of which was a trend), the negative schizophrenia group was significantly lower in state pleasant report compared to the nonnegative schizophrenia (ts ϭ 4.67, 2.67, and 3.32, ps ϭ Ͻ.001, .01, and .002, ds ϭ 1.25, 0.71, and 0.89 for the neutral, good, and bad conditions respectively), patient control (ts ϭ 2.74, 1.67, and 2.73, ps ϭ .009, .10, and .009, ds ϭ 0.86, 0.53, and 0.87 for the neutral, good, and bad conditions respectively) and nonpatient control (ts ϭ 1.98, 3.03, and 2.34, ps ϭ .05, .004, and .02, ds ϭ 0.53, 0.81, and 0.63 for the neutral good and bad conditions respectively) groups. This suggests that the negative schizophrenia group also showed state anhedonia.
Discussion
The present study tested the hypothesis that individuals with psychometrically defined schizotypy would show hedonic deficits as compared with patients with schizophrenia and nonpatient and patient control groups. In all, evidence supported this hypothesis. The schizotypy group reported significantly less state pleasant affect in response to a wide range of neutral, good, and bad stimuli as compared with each of the other groups. On the other hand, the schizotypy group was similar in trait pleasant affect to the patient groups, and these three groups were all abnormally low as com-2 Examination of the "constricted affect" and "no close friends" subscales of the brief version of the SPQ is generally not supported due to limited item coverage. Thus we were limited in examining "blunt affect" versus "anhedonia/avolition" in the schizotypy group. It is noteworthy that our version of the SPQ-B features an expanded response format, so our scores have improved range over measures using traditional true/false formats. Spearman's correlations between the pleasant ratings and the constricted affect and no close friends subscales were similar for the neutral condition (r ϭ Ϫ.27, p ϭ .02, and r ϭ Ϫ.21, p ϭ .07 respectively). Interestingly, the correlations for the good condition were somewhat higher for the constricted affect than the no close friends scales (r ϭ Ϫ.21, p ϭ .07, and r ϭ Ϫ.05, p ϭ .71 respectively). Although highly tenuous, this provides some support for the notion that, like what is seen in schizophrenia, state anhedonia is more highly related to constricted affect than "clinically" rated anhedonia. pared with the nonpatient control group. This suggests there is something unique about state, as opposed to trait, anhedonia that manifests in schizotypy as compared with schizophrenia. These findings did not appear to reflect comorbid anxiety or depression, nor the intrusion of co-occurring unpleasant affect at the time of making the pleasant ratings or differences in age between the samples.
Our results make two major contributions to the literature on state emotion across the schizophrenia spectrum. First, consistent with the extant literature on state anhedonia in psychometrically defined schizotypy, individuals with schizotypy, recruited from a college student population, showed state anhedonia that rivaled or exceeded that seen in chronic patients with schizophrenia. Although there was variability in state anhedonia across the schizotypy group as a function of negative trait severity, even nonnegative schizotypal individuals showed anhedonia during the good condition. In total, these findings speak to a heretofore unacknowledged affective paradox in the schizophrenia spectrum-that individuals with psychometrically defined schizotypy are as, or more, pathological in terms of state anhedonia than individuals with schizophrenia despite presumably being healthier and having better functioning in virtually every other conceivable domain.
A second contribution our results make to the extant literature is a challenge to the notion that patients with schizophrenia do not experience state anhedonia (e.g., Cohen & Minor, 2010; Kring & Moran, 2008; Pizzagalli, 2010) . While we did find that schizophrenia patients as a group reported normal pleasant experiences to good, neutral, and bad stimuli, a subgroup of schizophrenia patients showed significantly decreased pleasant report to each of these stimuli. As noted in the introduction, the literature examining state emotions in patients with pronounced negative symptoms versus those without is mixed, as two studies report evidence of state anhedonia in patients with negative symptoms (Cohen et al., 2003; Strauss et al., 2010) and two studies do not (Earnst & Kring, 1999; Trémeau et al., 2009) . It is important to note that each of these studies defined negative schizophrenia differently, so a reasonable resolution to this inconsistency in findings is that state anhedonia occurs in only schizophrenia patients with specific, but as yet unclear, negative symptoms (see below for further discussion). The point that some, but not all, patients with schizophrenia show state anhedonia is underscored by the present findings.
The present findings reveal three interesting knowledge gaps regarding emotion in schizophrenia spectrum disorders. First, it is unclear why, on the whole, psychometrically defined schizotypal subjects show more pronounced state anhedonia than chronic outpatients with schizophrenia. It is worth noting that the groups were similar in trait self-report, indicating that there is a disjunction in trait/state self report that exists for schizophrenia patients (as a group) that is not as pronounced in schizotypy. A second knowledge gap concerns the finding that individuals with negative schizotypy showed relatively severe state anhedonia across good-, bad-, and neutral-valenced stimuli, whereas individuals with nonnegative schizotypy showed similarly high state anhedonia only during the good condition. As noted above, this finding suggests that state anhedonia is present in most individuals with psychometrically defined schizotypy (broadly defined in terms of positive, negative, and disorganized traits), but that it is more contextually pervasive in individuals with negative schizotypy. The reasons for these differences are, as yet, unclear. A final knowledge gap involves clarifying the finding that state anhedonia was associated with clinical ratings of blunt affect-alogia, but not those related to clinical anhedonia in patients with schizophrenia. Similar results were seen in the schizotypy group. This finding is surprising given the conceptual overlap between clinically rated anhedonia and state anhedonia, but is consistent with prior findings that ratings of "consummatory" pleasure do not necessarily match ratings of emotional experience made by trained interviewers (Gard, Kring, Gard, Horan, & Green, 2007) . The reasons that blunt affect-alogia would be related to state anhedonia are not clear at this time, and reflect an interesting a venue for future research.
Some limitations of the present study warrant mention. First, we lacked a nonpatient control sample matched to the patient groups in age and education. Although it is unclear how this limitation could affect the main findings of this study, it is possible that use of an older, less-educated, control sample would reveal that our patient group was anhedonic. Given prior literature on this topic (Cohen & Minor, 2010; Kring & Moran, 2008) , this is unlikely. Second, the SAMS ratings used in this study, while an industry standard for studies employing the IAPS, may not have been particularly sensitive. Of note, there may have been floor effects for the unpleasant ratings. Third, the stimuli used in this study were limited to IAPS stimuli, and are certainly not representative of all stimuli individuals encounter in their environment. Our use of narratives to help individualize the slides and promote deeper processing may have improved the quality and ecological validity of the mood induction in this study. Alternatively, narratives may have contributed to the relatively low levels of unpleasant emotion reported across conditions. Fourth, there were differences in the number of stimuli administered to patients versus nonpatients. Given that statistically significant differences were observed between the nonpatient controls and schizotypy groups (who received identical procedures) and no differences were observed between the nonpatient control and schizophrenia groups (who received different procedures), the influence of this methodological detail on our findings is likely negligible. Fifth, there was considerable variability across patients in medication type, dosage, and medium, and it was impossible for us to meaningfully examine medication effects on our results. However, there is little reason to think that the patients would have reported state anhedonia if they were unmedicated at the time of testing (Kring, Kerr, Smith, & Neale, 1993) . Finally, our use of a psychometrically defined schizotypy sample recruited from a college sample may not be representative of all individuals with schizotypy. The use of a group that is functioning as well as they were represents a conservative test of our hypotheses. In summary, the findings from this project revealed a novel "paradox" in affective functions across the schizophrenia spectrum. Further research, likely using more sensitive and multidimensional measures of affect, will be required to clarify the nature of these seemingly paradoxical findings.
